Trend is your friend until it bends, and that’s when using option spreads is key. Not everyone is into trading MA crossovers (or whatever) for a measly 50% annual returns or whatever most traders make. If you want to make consistently triple digit returns with small drawdowns, then crowd following seldom works, one needs to be few steps ahead of the crowd. Most people are not comfortable to go against the crowd, and that’s a good thing
Even though most people disagreed with my analysis (that's understandable given this trade against the crowd sentiment), NVDA is showing further weakness. Will the weakness continue? I don’t know, the market will do whatever it wants to do. I'm sticking with my trade plan, continuing to adjust my option legs to take advantages of PA and IV changes, with aim to turn it into a zero risk trade as soon as possible.
315-375 gap ought to be filled at some point, selling puts around that but i don't take shares until is back to 200-250 range.
I wouldn’t want NVDA shares either, not only because of the technicals, but also because the insiders have been dumping the stock, which is another red flag.
I wouldn't call those minuscule sales compared to their overall positions "dumping". More like cashing in for some pocket change.
13 million, 28 million, 25 million, 51 million, 21 million, 37 million, 3 million, 7 million, 1 million, don’t sound like pocket changes when you are an insider. they probably get free new grants once the stock price level off, money printing loop.
Dude, look at the number of shares they own compared with the number of shares they sold, and do some mental math on the percentage of the their positions that they are "dumping". All you are is beguiled by dollar signs, can't see anything else and must conclude that the company is in trouble because of the pretty dollar signs. It's not Vivek's bio-tech FFS. You also cannot conceive that some of these people might be receiving the majority of their compensation in stocks, rather than cash.
it is all about the dollar sign, didn’t read anyone selling at 165 last year, same product cycle. even this small guy with 283 shares, lol, but i guess he/she didn’t have much left to sell.